Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2020-08-27 AGM Information
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Održana GS 2020
AGM Information Classification · 99% confidence The document text explicitly mentions the 'Redovna godišnja Glavna skupština Medike d.d.' (Annual General Meeting of Medika d.d.) and details the agenda items discussed and the decisions made, such as the approval of 2019 financial statements, dividend distribution, granting discharge to management/supervisory boards, and electing the auditor for 2020. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a mere announcement of the meeting (RPA) but rather the record or summary of the meeting's results.
2020-08-27 Croatian
Održana sjednica NO 27.8.2020.
AGM Information Classification · 99% confidence The document is a short announcement (759 characters) from MEDIKA d.d. dated August 27, 2020. The title is "OBAVIJEST O ODRŽANOJ SJEDNICI NADZORNOG ODBORA DRUŠTVA" (Notice of the Supervisory Board Meeting). The content states that the Supervisory Board approved the non-consolidated and consolidated financial statements for the period 01.01.-30.06.2020. Since this is a brief notice announcing the approval of financial reports rather than the reports themselves, and it doesn't fit specific categories like ER (Earnings Release, which is usually for key highlights) or IR (Interim Report, which would be the full report), it best fits the general category for regulatory announcements or a notice about corporate actions/reports. Given the context of announcing the approval of interim financial statements, it is a regulatory filing. However, since the document is very short and serves as a notification about an internal corporate event (Board meeting approving financials), and it is not a standard SEC form, the most appropriate general category is Regulatory Filings (RNS), as it is a mandatory disclosure. Revisiting the definitions: It is not an ER (Earnings Release) as it doesn't contain the results, nor is it the IR (Interim Report) itself. It is a notice about the board approving the interim report. This type of corporate governance/disclosure notice often falls under RNS if no other specific category applies. It is not a DIV, DIRS, or MANG announcement. Therefore, RNS is the best fit as a general regulatory disclosure.
2020-08-27 Croatian
Najava sjednice NO 27.8.2020.
Report Publication Announcement Classification · 99% confidence The document is a short announcement (851 characters) from MEDIKA d.d. dated August 24, 2020. The subject line is 'PREDMET – NAJAVA SJEDNICE NADZORNOG ODBORA' (SUBJECT - NOTICE OF SUPERVISORY BOARD MEETING). The text explicitly states that the Supervisory Board meeting will be held on 27.08.2020 to discuss financial reports for the period 01.01.-30.06.2020. This is not the financial report itself, but an announcement about a meeting where financial results will be reviewed. Since it is an announcement regarding the review/release of financial information, and it doesn't fit the specific categories like ER (Earnings Release, which is the initial announcement of results) or IR (Interim Report, which is the comprehensive report), it is best classified as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if the meeting's purpose was solely to publish the report. Given the context of a board meeting announcement concerning financial statements, RNS is the most appropriate general regulatory filing category for this type of notice, as it is a mandatory disclosure about internal corporate governance actions related to reporting.
2020-08-27 Croatian
Transakcije rukovoditelja Ivan Gregov 23.7.2020.
Director's Dealing Classification · 99% confidence The document is titled "OBAVIJEST O TRANSAKCIJAMA OSOBE KOJA OBAVLJA RUKOVODITELJSKE DUŽNOSTI" (Notification of Transactions by a Person Discharging Managerial Responsibilities). It details the acquisition of 450 shares of MEDIKA d.d. by Ivan Gregov, a Director of a subsidiary, on July 20, 2020. This type of mandatory disclosure, reporting insider transactions (director's dealing) under EU Market Abuse Regulation (MAR) Article 19, directly corresponds to the definition of Director's Dealing (DIRS). The document is a formal notification, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the specific transaction details.
2020-07-23 Croatian
Transakcije rukovoditelja Filip Šarunić 23.7.2020.
Director's Dealing Classification · 99% confidence The document is titled "OBAVIJEST O TRANSAKCIJAMA OSOBE KOJA OBAVLJA RUKOVODITELJSKE DUŽNOSTI" (Notification of Transactions by a Person Discharging Managerial Responsibilities). It explicitly details the acquisition of 450 shares by Filip Šarunić, identified as the Director of Pharmaceutical Sales (a managerial position), in compliance with Article 19 of the EU Market Abuse Regulation (MAR). This content directly corresponds to insider trading disclosure requirements concerning transactions by management personnel. Among the provided codes, 'Director's Dealing' (DIRS) is the most specific category for reporting personal share transactions by directors and executives.
2020-07-23 Croatian
Transakcije rukovoditelja Matko Galeković 23.7.2020.
Director's Dealing Classification · 100% confidence The document is titled "OBAVIJEST O TRANSAKCIJAMA OSOBE KOJA OBAVLJA RUKOVODITELJSKE DUŽNOSTI" (Notification of Transactions by Persons Discharging Managerial Responsibilities). It explicitly details the acquisition of 600 shares by Matko Galeković, a member of the Management Board (Uprave), citing compliance with Article 19 of the EU Market Abuse Regulation (MAR) and using the prescribed template for reporting such transactions. This type of filing specifically reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS).
2020-07-23 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.